Site #9002 — Boca Raton, Florida

Site #9002 is a clinical research site located in Boca Raton, Florida, United States 33486.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site #9002 has participated in 1 clinical trials.

Therapeutic areas: Parkinson's Disease.

Sponsors: Acorda Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boca Raton

Browse all research sites in Florida · View every site in Boca Raton

• University of Miami
• Boca Raton Regional Hospital /ID# 163659
• University of Miami-UHealth at Boca Raton (152)
• Raton Regional Hospital, Lynn Cancer Institute
• Lynn Cancer Center Boca Raton Regional Hospital, Lynn Cancer Institute
• Lynn Cancer Center at Boca Raton Regional Hospital ( Site 0063)
• Florida Atlantic University
• Boca Raton Regional Hospital, Lynn Cancer Institute, 701 NW 13th Street
• Boca Raton Hospital
• Charles E. Schmidt College of Medicine, Florida Atlantic University
• Boca Raton Regional Hospital/Lynn Cancer Institute
• Lynn Regional Cancer Center at Boca Raton Community Hospital - Main Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site #9002?

Site #9002 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site #9002 conducted?

Site #9002 has 1 clinical trials on record. Their work covers Parkinson's Disease.

Is Site #9002 accredited by Crixeo Clinical Trials?

Site #9002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site #9002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.